Hemolink hemoglobin-based red blood cell substitute: Phase II

Hemosol Inc. (TSE:HML), Toronto, Ontario Product: Hemolink hemoglobin-based red blood cell substitute Indication: Blood loss in elective and emergency surgeries, and possibly trauma Status: HML filed ...